Paul Rothenberg
Overview
Explore the profile of Paul Rothenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
504
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Awori Hayanga J, Tham E, Gomez-Tschrnko M, Mehaffey J, Lamb J, Rothenberg P, et al.
JTCVS Open
. 2024 May;
18:276-305.
PMID: 38690442
Background: Surgical volume is known to influence failure to rescue (FTR), defined as death following a complication. Robotic lung surgery continues to expand and there is variability in outcomes among...
2.
Awori Hayanga J, Luo X, Hasasna I, Rothenberg P, Reddy S, Mehaffey J, et al.
Ann Thorac Surg
. 2024 Apr;
119(2):325-332.
PMID: 38641193
Background: Race is a potent influencer of health care access. Geography and income may exert equal or greater influence on patient outcomes. We sought to define the intersection of race,...
3.
Rothenberg P, Lopez S, Thibault D, Pillai L, Minc S
Ann Vasc Surg
. 2024 Feb;
102:172-180.
PMID: 38307227
Background: Carotid artery stent (CAS) occlusion is a rare complication not well studied. We used a national dataset to assess real world CAS experience to determine the rate of stent...
4.
Rockhold M, Kunkel L, Lacoste J, Szymanski T, Rothenberg P, Zimmerman P, et al.
J Vasc Surg
. 2024 Jan;
79(6):1466-1472.e1.
PMID: 38278371
Objective: The role of direct oral anticoagulants (DOACs) in chronic limb-threatening ischemia after revascularization is unknown. Current evidence-based guidelines do not provide clear guidance on the role of anticoagulation or...
5.
Rothenberg P, Grau L, Kaplan L, Baraga M
Am J Orthop (Belle Mead NJ)
. 2016 Oct;
45(6):368-373.
PMID: 27737282
Football has the highest injury rate amongst popular American sports. Of those injuries that end seasons or careers, the knee is the most common culprit. This is of particular concern...
6.
Devineni D, Murphy J, Wang S, Stieltjes H, Rothenberg P, Scheers E, et al.
Clin Pharmacol Drug Dev
. 2016 May;
4(4):295-304.
PMID: 27136910
Absolute oral bioavailability of canagliflozin was assessed by simultaneous oral administration with intravenous [(14) C]-canagliflozin microdose infusion in nine healthy men. Pharmacokinetics of canagliflozin, [(14) C]-canagliflozin, and total radioactivity, and...
7.
Devineni D, Manitpisitkul P, Murphy J, Stieltjes H, Ariyawansa J, Di Prospero N, et al.
Clin Pharmacol Drug Dev
. 2016 May;
4(4):279-86.
PMID: 27136908
Canagliflozin, an orally active inhibitor of sodium glucose co-transporter 2, is approved for the treatment of type-2 diabetes mellitus. The effect of food on the pharmacokinetics of 300 mg canagliflozin,...
8.
Polidori D, Sha S, Heise T, Natarajan J, Artis E, Wang S, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
4(1):12-7.
PMID: 27127999
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves indices of β-cell function estimated based on circulating C-peptide and glucose concentrations (e.g., Homeostasis Model Assessment [HOMA2-%B], meal tolerance test-based indices). However,...
9.
Rosenthal N, Meininger G, Ways K, Polidori D, Desai M, Qiu R, et al.
Ann N Y Acad Sci
. 2015 Aug;
1358:28-43.
PMID: 26305874
The sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin is a novel treatment option for adults with type 2 diabetes mellitus (T2DM). In patients with hyperglycemia, SGLT2 inhibition lowers plasma glucose...
10.
Devineni D, Vaccaro N, Murphy J, Curtin C, Mamidi R, Weiner S, et al.
Int J Clin Pharmacol Ther
. 2014 Nov;
53(2):115-28.
PMID: 25407255
Objective: Canagliflozin, a sodium-glucose co-transporter 2 inhibitor, approved for the treatment of type-2 diabetes mellitus (T2DM), is metabolized by uridine diphosphate-glucuronosyltransferases (UGT) 1A9 and UGT2B4, and is a substrate of...